TOGNON, Mauro
 Distribuzione geografica
Continente #
NA - Nord America 31.054
AS - Asia 17.972
EU - Europa 17.698
SA - Sud America 3.173
AF - Africa 476
OC - Oceania 49
Continente sconosciuto - Info sul continente non disponibili 14
Totale 70.436
Nazione #
US - Stati Uniti d'America 30.217
IT - Italia 7.577
SG - Singapore 6.876
CN - Cina 4.202
FI - Finlandia 2.499
BR - Brasile 2.493
VN - Vietnam 2.183
DE - Germania 1.771
UA - Ucraina 1.332
HK - Hong Kong 1.326
GB - Regno Unito 1.060
TR - Turchia 936
FR - Francia 613
SE - Svezia 553
NL - Olanda 509
PL - Polonia 501
RU - Federazione Russa 470
JP - Giappone 451
IN - India 449
BD - Bangladesh 408
CA - Canada 397
MX - Messico 323
ID - Indonesia 257
AR - Argentina 255
ZA - Sudafrica 186
IQ - Iraq 166
ES - Italia 135
EC - Ecuador 120
BE - Belgio 93
PK - Pakistan 87
AT - Austria 85
CO - Colombia 80
CZ - Repubblica Ceca 78
MY - Malesia 77
LT - Lituania 76
VE - Venezuela 75
MA - Marocco 66
CH - Svizzera 64
UZ - Uzbekistan 59
SA - Arabia Saudita 58
EG - Egitto 56
PH - Filippine 54
IE - Irlanda 53
JO - Giordania 44
CL - Cile 43
KR - Corea 40
AU - Australia 39
IR - Iran 39
AE - Emirati Arabi Uniti 35
TN - Tunisia 35
PY - Paraguay 34
KE - Kenya 33
RO - Romania 32
PE - Perù 29
NP - Nepal 26
DK - Danimarca 24
JM - Giamaica 24
ET - Etiopia 23
IL - Israele 23
AL - Albania 22
TH - Thailandia 21
OM - Oman 20
PT - Portogallo 20
TW - Taiwan 20
UY - Uruguay 20
DZ - Algeria 19
NO - Norvegia 19
BO - Bolivia 18
AZ - Azerbaigian 16
CR - Costa Rica 16
SN - Senegal 14
GR - Grecia 13
KG - Kirghizistan 13
KZ - Kazakistan 12
PA - Panama 12
RS - Serbia 12
LV - Lettonia 11
PS - Palestinian Territory 11
SK - Slovacchia (Repubblica Slovacca) 11
TT - Trinidad e Tobago 11
HN - Honduras 10
LB - Libano 10
SI - Slovenia 10
BH - Bahrain 9
DO - Repubblica Dominicana 9
GT - Guatemala 8
HR - Croazia 8
MD - Moldavia 8
NI - Nicaragua 8
EU - Europa 7
NZ - Nuova Zelanda 7
SV - El Salvador 7
GE - Georgia 6
HU - Ungheria 6
NG - Nigeria 6
MN - Mongolia 5
SC - Seychelles 5
SM - San Marino 5
AM - Armenia 4
BA - Bosnia-Erzegovina 4
Totale 70.322
Città #
Singapore 4.285
Ashburn 3.739
San Jose 2.371
Fairfield 2.148
Helsinki 2.084
Woodbridge 2.038
Chandler 1.428
Jacksonville 1.420
Houston 1.351
Beijing 1.297
Hong Kong 1.291
Santa Clara 1.290
Ann Arbor 1.145
Seattle 838
Wilmington 780
Milan 778
Cambridge 690
Ho Chi Minh City 688
New York 641
Los Angeles 592
Ferrara 552
Dallas 544
Rome 528
Hanoi 506
Izmir 470
Warsaw 465
Nanjing 429
Tokyo 425
Munich 372
Princeton 354
Council Bluffs 347
The Dalles 340
Lauterbourg 306
São Paulo 291
Bologna 241
Boardman 237
Shanghai 222
San Diego 205
Mexico City 202
Orem 200
Addison 166
Buffalo 162
London 160
Jakarta 158
Brooklyn 143
Shenyang 138
Nanchang 136
Turku 128
Florence 123
Da Nang 121
Montreal 121
Denver 119
Frankfurt am Main 119
Bremen 116
Chicago 115
Johannesburg 115
Chennai 113
Hefei 112
Amsterdam 110
Tianjin 110
Bari 106
Stockholm 103
Toronto 102
Atlanta 100
Haiphong 99
Naples 98
Dearborn 94
Poplar 88
Verona 87
Moscow 86
Rio de Janeiro 84
Hebei 83
Phoenix 83
San Francisco 78
Manchester 76
Palermo 76
San Mateo 76
Brussels 75
Genoa 75
Redwood City 70
Turin 70
Boston 68
Jiaxing 66
Changsha 64
Padova 64
Baghdad 63
Falkenstein 58
Guangzhou 57
Falls Church 55
Istanbul 53
Ankara 51
Hải Dương 51
Tashkent 51
Brescia 50
Catania 50
Modena 50
Nuremberg 50
Belo Horizonte 48
Ottawa 48
Paris 48
Totale 43.569
Nome #
Associazione tra il virus oncogeno della scimmia SV40 e i linfomi umani 3.355
ANALISI DI PCR QUALITATIVA E QUANTITATIVA DEL DNA DEL VIRUS ONCOGENO SV40 IN CAMPIONI DI SANGUE DI DONATORI DI CASALE MONFERRATO, CITTÀ CONTAMINATA DALL’AMIANTO 2.565
BREVETTO/PATENT FI2005A000038. TITOLO: OSTEOBLASTI UMANI INGEGNERIZZATI CHE ESPRIMONO LA PROTEINA FLUORESCENTE eGFP 2.022
Investigation on silent bacterial infections in specimens from pregnant women affected by spontaneous miscarriage 512
Citocompatibilità di biomateriali: osteoblasti umani ingegnerizzati fluorescenti 447
Merkel cell carcinomas arising in autoimmune disease affected patients treated with biologic drugs including anti-TNF 439
Antibodies reacting to mimotopes of Simian virus 40 large T antigen, the viral oncoprotein, in sera from children 433
Footprints of BK and JC polyomaviruses in specimens from females affected by spontaneous abortion 367
Gene expression changes in progression of cervical neoplasia revealed by microarray analysis of cervical neoplastic keratinocytes 361
Droplet-digital PCR assay to detect Merkel cell polyomavirus sequences in chorionic villi from spontaneous abortion affected females 349
MTHFR gene promoter hypermethylation correlates with semen samples of infertile couples with recurrence spontaneous abortion 338
High Human Papillomavirus DNA loads in Inflammatory Middle Ear Diseases 325
Adult Stem Cells for Bone Regeneration and Repair 320
Hypermethylation-induced inactivation of the IRF6 gene as a possible early event in progression of vulvar squamous cell carcinoma associated with lichen sclerosus 318
Circulating microRNAs found dysregulated in ex-exposed asbestos workers and pleural mesothelioma patients as potential new biomarkers 318
Association Between Simian Virus 40 and Human Tumors 313
Test ELISA indiretto per l’identificazione nel siero e in altri fluidi umani di anticorpi contro il virus SV40 mediante l’uso di peptidi sintetici specifici della sua regione precoce, codificante per l’oncoproteina antigene T grande 308
P2X7 targeting inhibits growth of human mesothelioma 303
Innovative Biomaterials for Bone Regrowth 298
Drugs, environmental factors, loci and genes involved in nonsyndromic orofacial cleft 286
Environmental doses of perfluorooctanoic acid change the expression of genes in target tissues of common carp 285
Reactivation of infectious simian virus 40 from normal human tissues 283
Association of retinoic acid receptor ß gene with onset and progression of lichen sclerosus-associated vulvar squamous cell carcinoma 275
Antibodies reacting with Simian Virus 40 capsid protein mimotopes in serum samples of patients affected by uveal melanoma 272
Specific Antibodies Reacting with SV40 Large T Antigen Mimotopes in Serum Samples of Healthy Subjects 270
Analysis of HSV isolated from patients with unilateral and bilateral herpetic keratitis 263
Chorionic Tissue and Peripheral Blood as Potential Reservoir of Pathogens Responsible of Reccurent Spontaneous Miscarriage in Women. Preliminary Results 262
A molecular epidemiology case control study on pleural malignant mesothelioma 260
Breast Cancer and Simian Virus 40 Infection 257
ASSOCIAZIONE TRA I LINFOMI NON-HODGKIN E IL VIRUS ONCOGENO SV40 . 251
Simian Virus 40 (SV40) antibodies in elderly subjects 250
New Perspectives on Diagnosis and Therapy of Malignant Pleural Mesothelioma 249
Serological evidence of an early seroconversion to Simian Virus 40 in healthy children and adolescents 247
Age-specific seroprevalence of human polyomavirus 12 and Saint Louis and New Jersey polyomaviruses 246
A BETTER CLINICAL OUTCOME OF MERKEL CELL CARCINOMA PATIENTS IS ASSOCIATED WITH A HIGH LEVEL OF ANTIBODIES AGAINST MERKEL CELL POLYOMAVIRUS, A NEW SMALL DNA TUMOR VIRUS 245
Characterization of a herpes simplex virus type 1 mutant resistant to benzhydrazone, a selective inhibitor of herpesvirus glycosylation 242
BK virus, JC virus and simian virus 40 infection in humans, and association with human tumors 242
Specific IgG antibodies react to mimotopes of BK Polyomavirus, a small DNA tumor virus, in healthy adult sera 242
Papilloma and polyoma DNA tumor virus sequences in female genital tumors 241
Asbestos induces mesothelial cell transformation via HMGB1-driven autophagy 241
SV40-immortalized human fibroblasts as a source of SV40 infectious virions 238
VIRAL ONCOGENESIS PREFACE 235
A3 RECEPTORS ARE OVEREXPRESSED IN PLEURA FROM PATIENTS WITH MESOTHELIOMA AND REDUCE CELL GROWTH VIA AKT/NUCLEAR FACTOR-KB PATHWAY 234
MICRORNAS DYSREGULATION IN HUMAN MALIGNANT PLEURAL MESOTHELIOMA 233
Advanced Molecular and Immunological Diagnostic Methods to Detect SARS-CoV-2 Infection 233
ASPETTI GENETICI DELLE PATOLOGIE DEL COLON 230
Detection of Merkel Cell Polyomavirus DNA in Serum Samples of Healthy Blood Donors 230
BK and JC human polyomaviruses and simian virus 40: natural history of infection in humans, experimental oncogenicity and association with human tumors 229
Serum antibodies from epileptic patients react, at high prevalence, with simian virus 40 mimotopes 228
Biomaterials as bone graft substitutes for spine surgery: from preclinical results to clinical study. 228
Tracing Males From Different Continents by Genotyping JC Polyomavirus in DNA From Semen Samples 227
SERPINA1 Gene Promoter Is Differentially Methylated in Peripheral Blood Mononuclear Cells of Pregnant Women 227
Serologic investigation on undifferentiated nasopharyngeal carcinoma and Simian Virus 40 infection 224
A3 Receptors are Overexpressed in Pleura from Mesothelioma Patients and Reduce Cell Growth via Akt/NF-kB Pathway. 222
Combined segregation and linkage analysis of nonsyndromic orofacial cleft in two candidate regions 222
A herpes simplex virus type 1 mutant resistant to benzhydrazone, an inhibitor of glycoprotein synthesis in herpesvirus-infected cells. Preliminary mapping of benzhydrazone-resistance and of a novel syncitial mutation 221
Establishment of Keratinocyte Colonies From Small-Sized Cervical Intraepithelial Neoplasia Specimens 221
HPV-based strategy in follow-up of patients treated for high-grade cervical intra-epithelial neoplasia: 5-year results in a public health surveillance setting 221
Specific antibodies reacting with simian virus 40 capsid protein mimotopes in serum samples from healthy blood donors 220
SPECIFIC ANTIBODIES AGAINST THE ONCOGENIC VIRUS SV40 IN SERA OF BLOOD DONORS AND ONCOLOGIC PATIENTS DETECTED BY AN INNOVATIVE INDIRECT ELISA TEST 219
A3 adenosine receptors are overexpressed in pleura from patients with mesothelioma and reduce malignant mesothelioma cell growth 219
Association between the JC polyomavirus infection and male infertility 219
Mesenchymal stem cells from patients to assay bone graft substitutes 218
Serum IgG against Simian Virus 40 antigens are hampered by high levels of sHLA-G in patients affected by inflammatory neurological diseases, as multiple sclerosis 218
Espressione dell'oncoproteina virale antigene T-grande di SV40 in carcinomi mammari infiltranti valutata su Tissue micro arrays (TMAs) 216
Bioactive Materials for Soft Tissue Repair 214
Enhanced inhibition of virus DNA synthesis in hepatocytes by trifluorothymidine coupled to asialofetuin 213
COVID-19 Is a Multifaceted Challenging Pandemic Which Needs Urgent Public Health Interventions 213
A FLUORESCENT OSTEOBLAST-LIKE CELL LINE FOR THE ASSAY OF BIOMATERIAL FEATURES 213
B-LYMPHOCYTES FROM HEALTHY BLOOD DONORS TRANSFORMED BYSV40, A SMALL DNA TUMOR VIRUS 212
Serum IgG antibodies from healthy subjects up to 100 years old react to JC polyomavirus 211
Strong evidence of linkage disequilibrium between polymorphisms at the IRF6 locus and nonsyndromic cleft lip with or without cleft palate, in an Italian population 211
Simian virus 40-like sequences from early and late regions in human thyroid tumors of different histotypes 210
Activity of the matrix metalloproteinase 9 promoter in human normal and tumor cells 210
GENETICS OF THE NONSYNDROMIC CLEFT OF THE LIP WITH OR WITHOUT CLEFT OF THE PALATE 210
Premi Natta e Copernico 209
BK virus, JC virus and Simian Virus 40 infection in humans, and association with human tumors. In: POLYOMAVIRUSES AND HUMAN DISEASES 207
Maternal MTHFR Variant Forms Increase the Risk in Offspring of Isolated Nonsyndromic Cleft Lip With or Without Cleft Palate 207
Specific Detection of Serum Antibodies against BKPyV, A Small DNA Tumour Virus, in Patients Affected by Choroidal Nevi 207
Gram-negative bacterial lipopolysaccharide retention by a positively charged new-generation filter. 206
Merkel cell polyomavirus DNA sequences in the buffy coats of healthy blood donors 206
ALLESTIMENTO DI UN NUOVO SAGGIO ELISA INDIRETTO PER RIVELARE ANTICORPI SPECIFICI CONTRO L’ONCOPROTEINA ANTIGENE T GRANDE DI SV40 NEI SIERI DI INDIVIDUI SANI E PAZIENTI ONCOLOGICI. 206
Protocol for the long-term culture of human primary keratinocytes from the normal colorectal mucosa 206
Characterization of virus obtained from MDBK cells persistently infected with a variant of herpes simplex virus type 1 strain MP [HSV-1(MP)] 205
High prevalence of antibodies reacting to mimotopes of Simian virus 40 large T antigen, the oncoprotein, in serum samples of patients affected by non-Hodgkin lymphoma 205
The endoplasmic reticulum mitochondrial calcium cross talk is downregulated in malignant pleural mesothelioma cells and plays a critical role in apoptosis inhibition 204
Adding a “Notch” to Cardiovascular Disease Therapeutics: A MicroRNA-Based Approach 204
New Insights into Molecular Oncogenesis and Therapy of Uveal Melanoma 202
Association between oncogenic human papillomavirus type 16 and Killian polyp 202
High incidence of BK virus large T-antigen coding sequences in normal human tissues and tumors of different histotypes 201
Simian virus 40 infection in humans and association with human diseases: results and hypotheses 200
High prevalence of serum antibodies reacting with simian virus 40 capsid protein mimotopes in patients affected by malignant pleural mesothelioma 200
Different simian virus 40 genomic regions and sequences homologous with SV40 large T antigen in DNA of human brain and bone tumors and of leukocytes from blood donors 198
Significant prevalence of antibodies reacting with simian virus 40 mimotopes in sera from patients affected by glioblastoma multiforme 198
MicroRNAs as potential biomarkers and innovative therapeutic targets in retinal degenerations 198
Human Brain Tumors and Simian Virus 40 196
FHIT oncosuppressor gene expression profile in human anal cancers. 196
Hemorrhagic cystitis in children undergoing bone marrow transplantation: A putative role for simian virus 40 195
Human adipose stem cells induced to osteogenic differentiation by an innovative collagen/hydroxylapatite hybrid scaffold 195
Simian virus 40 sequences in human lymphoblastoid B-cell lines 194
Totale 31.896
Categoria #
all - tutte 275.569
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 13.147
Totale 288.716


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021254 0 0 0 0 0 0 0 0 0 0 0 254
2021/20223.432 127 369 225 223 185 141 172 208 164 248 314 1.056
2022/20233.639 401 262 189 376 614 499 160 282 444 58 222 132
2023/20242.565 203 230 142 107 222 384 154 152 94 97 129 651
2024/202511.892 271 349 772 420 1.232 1.291 1.026 691 1.740 1.254 1.730 1.116
2025/202631.293 2.549 1.286 2.192 4.116 4.365 2.155 3.446 1.855 4.638 3.152 1.288 251
Totale 71.110